| |
| | Index - Tessera, Inc (Site not responding. Last check: 2007-10-08) |
 | | Tessera, Inc is a Seattle-based, biotechnology company dedicated to developing new, cutting-edge diagnostic products for the early detection of prostate and colon cancers. |
 | | Using new, patented technology discovered by leading scientists from Johns Hopkins University's School of Medicine, (Baltimore, Maryland) and from the University of Pittsburgh, (Pittsburgh, Pennsylvania), Tessera is developing diagnostic tests that are many times more sensitive and more accurate than other methods currently used. |
 | | A funded research program with Dr. Robert Getzenberg is currently underway at the Brady Urological Research Institute at Johns Hopkins to develop antibodies for the detection of early-stage prostate cancer and colon cancer. |
| www.tesserainc.com (155 words) |
|